DR. YAZICI is an assistant professor of medicine at New York University and is the director of the Seligman Center for Advanced Therapeutics at the NYU Hospital for Joint Diseases in New York City. He disclosed a financial relationship with Centocor Inc., Bristol-Myers Squibb Co., Celgene Corp., Genentech Inc., Pfizer Inc., Roche, and UCB Inc.